Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Atavistik Bio, Inc
Wake Forest University Health Sciences
K36 Therapeutics, Inc.
Varian, a Siemens Healthineers Company
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
University of California, Davis
National Institutes of Health Clinical Center (CC)
University of California, Irvine
Blue Earth Therapeutics Ltd
Washington University School of Medicine
Cedars-Sinai Medical Center
Spanish Oncology Genito-Urinary Group
Indiana University
H. Lee Moffitt Cancer Center and Research Institute
DL Analytics
Centre Hospitalier Universitaire de Nīmes
National Institutes of Health Clinical Center (CC)
NanOlogy, LLC
Wake Forest University Health Sciences
Dana-Farber Cancer Institute
University Health Network, Toronto
National Institutes of Health Clinical Center (CC)
AgonOx, Inc.
Memorial Sloan Kettering Cancer Center
Indiana University
RenJi Hospital
M.D. Anderson Cancer Center
Eli Lilly and Company